The Methane Dysbiosis Score on a GI Effects panel is an assessment of the likelihood of methane-dominant dysbiosis in the gastrointestinal tract. Methane production in the gut is primarily attributed to methanogenic archaea, particularly Methanobrevibacter smithii. These organisms thrive in an anaerobic environment and use hydrogen, a byproduct of bacterial fermentation, to produce methane. Elevated methane levels are often associated with a slower transit time in the intestines, contributing to symptoms such as constipation and bloating, as well as potential disruptions in gut motility.
The score is calculated based on the abundance of methanogenic organisms in the stool sample and serves as a marker of microbial imbalance rather than a direct diagnostic tool for a specific condition. A high Methane Dysbiosis Score may indicate an overgrowth of methanogens, which could be contributing to symptoms of small intestinal bacterial overgrowth (SIBO), methane-dominant SIBO, or other forms of dysbiosis. Conversely, a low score suggests a minimal contribution of methane-producing organisms to gut health.
Addressing a high Methane Dysbiosis Score often involves strategies aimed at restoring microbial balance. These may include dietary modifications (such as reducing fermentable carbohydrates that fuel hydrogen production), antimicrobial therapies targeting methanogens, and the use of prokinetics to improve gut motility. Understanding the Methane Dysbiosis Score in conjunction with other biomarkers on the GI Effects panel helps clinicians develop a more tailored approach to managing symptoms and optimizing gut health.
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.